封面
市场调查报告书
商品编码
1524203

无菌医疗包装:市场占有率分析、产业趋势与统计、成长预测(2024-2029)

Sterile Medical Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

出版日期: | 出版商: Mordor Intelligence | 英文 173 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

无菌医疗包装市场规模预计到 2024 年为 566.7 亿美元,预计到 2029 年将达到 850.5 亿美元,在预测期内(2024-2029 年)复合年增长率为 8.46%。

无菌医疗包装市场

灭菌是医疗产业的重要加工步骤。因此,无菌包装产品和无菌屏障系统在业界变得越来越重要。无菌医疗包装不可重复使用,可作为防止微生物感染的屏障。使用塑胶和纸张具有重量轻、可回收、耐用等优点。

主要亮点

  • 医疗製药业对包装的需求不断增长,以保护产品在运输过程中免受环境因素(例如潮湿)的影响。此外,对包装技术的投资增加,包括使用先进设备来提高效率,正在推动对确保医疗设备和药品完整性和无菌性的包装解决方案的需求。
  • 塑胶材料的进步正在推动市场,塑胶被用于医疗设备和消耗品,包括个人防护设备。塑胶对于基本医疗保健的生产、包装和分配也至关重要。各种製药和医疗设备包装製造商正在透过引入更好的无菌包装解决方案来不断改进产品系列。
  • 2024年1月,全球领先的微生物解决方案专家Cherwell宣布推出革命性的Redipor Beta Bag。这种具有多种用途的创新塑胶袋有可能降低与环境监测 (EM) 程序相关的风险、成本和时间,同时持续生产无菌药品。最近推出的转移袋经过彻底检验,旨在与隔离器和 RABS 系统中常见的 190mm Getinge Alpha 连接埠无缝配合。这确保了信用者电镀介质的无污染转移,从而实现高效生产并显着降低风险。
  • 由于处方药成本上升和安全问题日益严重,非处方药 (OTC) 变得越来越受欢迎。此外,疼痛、压力和皮肤病等特定疾病的增加也导致成药的消费增加。对成药的需求可能会增加整个製药业对无菌包装的需求。
  • 医疗无菌包装领域不允许任何污染或感染的可能性。因此,该细分市场在全球范围内受到严格监管,以确保产品安全,免受污染和篡改,并确保准确显示剂量、製造和有效期等重要资讯。然而,在患者安全至关重要的行业中,遵循详细的包装标准有时可能变得过于重要。包装法规的动态性质给该行业的製造商带来了挑战。
  • 自 COVID-19 大流行后,全球医疗药品支出不断增加,导致对医疗无菌包装的需求增加。

医用无菌包装的市场趋势

医药产业占主要市场占有率

  • 全球製药业在过去几年中经历了显着成长,这主要归功于技术进步和市场创新。根据国家医学图书馆的数据,FDA 在 2023 年核准了 55 种新药,这正在推动市场成长。
  • 根据世界卫生组织(WHO)的资料,2019年60岁以上人口10亿,预计2030年将增加至14亿,2050年将增加至21亿人。人口老化和医疗产品使用量的增加推动了製药业对无菌包装的需求。癌症、糖尿病和肠道疾病等需要长期服用药物的疾病的增加正在推动市场的成长。
  • 药品和药品的无菌包装可确保产品在供应链过程中不受污染、无尘且安全,进而推动市场成长。热成型托盘、泡壳包装和小袋等包装有助于防止患者使用的有害细菌传播。
  • 主要企业努力透过无菌包装提供最高水准的保护。杜邦德内穆尔公司等公司提供具有高强度和微生物屏障的无菌药品包装,以帮助在运输和储存过程中保持无菌。
  • 此外,根据 IQVIA 2023 年 1 月发布的报告,全球医疗药品支出不断增加,2022 年将达到约 14,820 亿美元。

亚太地区将显着成长

  • 由于对医疗保健和医疗行业的日益重视,亚太地区无菌包装市场预计将成长。医疗产业不断增长的需求导致医疗设备和手术器械包装的蓬勃发展。
  • 该地区无菌包装产业的开拓得益于灭菌技术和智慧设计包装解决方案的新兴市场推动了市场成长。
  • 由于人口老化、慢性病增加以及医疗技术进步,全球医疗产业持续成长,无菌医疗设备包装的需求预计将相应增加。这种增长是由对感染控制和患者安全的日益关注进一步推动的,这导致医疗设备製造商优先考虑使用无菌包装,以确保产品的完整性和无菌性。
  • 对病人安全的日益重视和对一次性医疗产品的需求增加正在推动对高品质无菌包装解决方案的需求。具有增强耐用性和阻隔性的无菌包装解决方案的创新也是全部区域的趋势。

无菌医疗包装产业概况

由于品牌身份验证、强有力的竞争策略和透明度等影响市场的因素,无菌医疗包装市场正在变得半固体。强大的品牌是良好业绩的代名词,因此我们预期老字型大小企业将拥有优势。此外,大规模投资增加了现有参与企业的退出壁垒,推动产业竞争更加激烈。此外,供应商正在提高其技术力并加剧市场竞争。市场参与企业包括 Amcor Group GmbH、Dupont De Nemours Inc.、Steripack Group Limited、Wipak Group 和 Placon Corporation。

  • 2024年4月,杜邦宣布推出Tyvek Protech PSU即剥即贴衬垫,这是一款全新屋顶衬垫产品。这款新产品旨在提供高性能、耐高温和抗紫外线、防滑行走表面、易于安装的分离式衬里、ICC-ES 代码报告以及着名的 FL/Miami-Dade 认证。
  • 2024 年 2 月,Spectrum 宣布计划透过扩大其哥斯达黎加工厂以纳入无菌杜邦Tyvek医疗包装能力来加强其医疗管业务。埃雷迪亚工厂从 36,000 平方英尺扩建至 52,000 平方英尺,旨在提高产能并加快服务交付。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行概述

第四章市场洞察

  • 市场概况
  • 产业价值链分析
  • 产业吸引力-波特五力分析
  • 当前地缘政治情势对市场的影响

第五章市场动态

  • 市场驱动因素
    • 严格的感染控制法规预计将推动无菌产品的需求
    • 最近产能增加
    • 塑胶领域的材料进步
  • 市场问题
    • 法规的动态性质要求製造商应对带来材料可用性挑战的当地因素。

第六章 市场细分

  • 依材料类型
    • 塑胶
      • 聚丙烯(PP)
      • 聚酯纤维
      • 聚苯乙烯(PS)
      • 聚氯乙烯(PVC)、高密度聚苯乙烯(HDPE)等
    • 纸板
    • 玻璃
    • 其他的
  • 依产品类型
    • 热成型托盘
    • 无菌瓶/容器
    • 袋子和袋子
    • 泡壳包装
    • 管瓶和安瓿
    • 预填充式注射器
  • 按用途
    • 药品
    • 手术/医疗设备
    • 体外诊断(IVD)
    • 其他的
  • 按灭菌类型
    • 化学灭菌
    • 放射线杀菌
    • 压力/温度灭菌
  • 按地区
    • 北美洲
    • 欧洲
    • 亚洲
    • 澳洲/纽西兰
    • 拉丁美洲
    • 中东/非洲

第七章 竞争格局

  • 公司简介
    • Amcor Group GmbH
    • Dupont De Nemours Inc.
    • Steripack Group Limited
    • Wipak Group
    • Placon Corporation
    • Riverside Medical Packaging Company Ltd
    • Tekni-Plex Inc.
    • BillerudKorsnas AB
    • Sonoco Products Co
    • DWK Life Sciences
    • Technipaq Inc.
    • 3M Company
    • Nelipak Healthcare Packaging
    • Oliver Healthcare Packaging
    • Beacon Converting Inc.
    • Paxxus Inc.
    • Spectrum Plastics Group
    • Sterimed Holdings SaS
    • Sigma Medical Supplies Corporation
    • Charter Next Generation
    • Berry Global Inc.
    • Sealed Air Corporation

第八章市场展望

简介目录
Product Code: 69033

The Sterile Medical Packaging Market size is estimated at USD 56.67 billion in 2024, and is expected to reach USD 85.05 billion by 2029, growing at a CAGR of 8.46% during the forecast period (2024-2029).

Sterile Medical Packaging - Market

Sterilization is an important processing step in the healthcare industry. Therefore, sterile packaging products or sterile barrier systems are becoming increasingly important in the industry. Sterile medical packaging is non-reusable and acts as a barrier against microbial infection. Using plastic and paper offers lightweight, recyclability, and durability advantages.

Key Highlights

  • The medical and pharmaceutical industries are experiencing a growing need for packaging to safeguard products from environmental factors like moisture while in transit. Additionally, the rising investments in packaging technologies, including the use of advanced equipment to enhance efficiency, are driving up the demand for packaging solutions that guarantee the integrity and sterility of medical devices and pharmaceuticals.
  • Material advancements in plastics drive the market, using plastics in medical devices and supplies, including personal protective equipment. Plastics are also crucial in essential medical production, packaging, and distribution. Various pharmaceutical and medical device packaging manufacturers are constantly improving their product portfolio by introducing better sterile packaging solutions.
  • In January 2024, global microbiology solution expert Cherwell announced the launch of the groundbreaking Redipor Beta Bag. This innovative plastic bag for multiple uses has the potential to decrease risk, expenses, and time involved in environmental monitoring (EM) procedures while continuously manufacturing sterile medicinal products. The recently introduced transfer bags have been thoroughly validated and are designed to work seamlessly with 190mm Getinge Alpha Ports commonly found in isolators and RABS systems. This ensures a contamination-free transfer of creditor-plated media, allowing for efficient production and a notable decrease in risk.
  • The over-the-counter (OTC) popularity is growing because of the rising prescription drug costs and increasing concerns over safety. Further, the increase in certain disorders, such as those related to pain, stress, and skin conditions, contributes to the growing consumption of OTC drugs. The demand for OTC drugs will likely increase the demand for sterile packaging across the pharmaceutical industry.
  • The medical sterile packaging sector doesn't allow any room chances for contamination and infections. Therefore, the sector is strictly regulated globally to guarantee the safety of products from contamination and tampering and to ensure that vital information regarding dosage, usage, manufacturing, expiration dates, and other details is accurately presented. However, in an industry where patient safety is paramount, following detailed criteria that control the packaging sometimes becomes overly critical. The dynamic nature of packaging regulations makes it challenging for the manufacturers in the industry.
  • The spending on medical and pharmaceuticals has been increasing globally since the post-COVID-19 pandemic, consequently increasing the demand for medical sterile packaging.

Sterile Medical Packaging Market Trends

Pharmaceutical Sector to Hold Major Market Share

  • The global pharmaceutical industry has experienced significant growth in the past years, mainly due to technological advancements and innovations in the market. According to the National Library of Medicine, the FDA approved 55 new drugs in 2023, which drives the market's growth.
  • According to data from the World Health Organization, the number of people aged 60 years and older in 2019 was 1 billion, which is likely to increase to 1.4 billion by 2030 and 2.1 billion by 2050, rspectively. The demand for sterile packaging in the pharmaceutical industry is attributable to the rising aging population with high medical product use. Growth in diseases, including cancer, diabetes, and bowel diseases, requires long-term use of medicines and drugs, thus boosting the market's growth.
  • The pharmaceutical sterile packaging for drugs and medicines ensures the products are contamination, dust-free, and secure during the supply chain, propelling the market growth. Packaging such as thermoform trays, blister packs, and pouches help prevent the spread of harmful germs used by patients.
  • Major players strive to provide the highest level of protection through sterile packaging. Companies such as DuPont de Nemours Inc. provide pharmaceutical sterile packaging with high strength and microbial barriers to help preserve sterility during shipping and storage.
  • Furthermore, according to the IQVIA report published on January 2023, global spending on medicine and pharmaceuticals is constantly growing, with approximately USD 1.482 trillion in 2022; encouragingly, the pharmaceutical and medical expenditure is expected to increase to around 1.917 trillion by 2027.

Asia Pacific to Register Major Growth

  • The sterile packaging market in Aisa pacific, is estimated to rise due to the growing emphasis on the healthcare and medical industry. The rising demand for the medical industry has resulted in a boom in the packaging of medical devices and surgical instruments.
  • The development in the sterile packaging industry in the region is attributable to the rising advancements in sterilization technologies and intelligent design packaging solutions that boost the market's growth.
  • As the healthcare industry continues to grow globally, driven by an aging population, increasing prevalence of chronic diseases, and advancements in medical technology, the demand for sterile medical device packaging is expected to rise correspondingly. This growth is further driven by the heightened emphasis on infection control and patient safety, prompting medical device manufacturers to prioritize the use of sterile packaging to ensure the integrity and sterility of their products.
  • Increasing emphasis on patient safety and rising demand for single-use medical products has resulted in a growing demand for high-quality sterile packaging solutions. Technological innovation in sterile packaging solutions with enhanced durability and barrier properties is also trending across the region.

Sterile Medical Packaging Industry Overview

The sterile medical packaging market is semi-consolidated with various factors affecting the market, such as brand identity, powerful competitive strategy, and degree of transparency. Strong brands are synonymous with good performance, so long-standing players are expected to have the upper hand. Moreover, the involvement of large-scale investment also increases the barriers to exit for existing players, thereby pushing the industry toward improved competition. Additionally, vendors are enhancing their technological capabilities, thereby intensifying market competition. Some of the players in the market are Amcor Group GmbH, Dupont De Nemours Inc.,Steripack Group Limited, Wipak Group, Placon Corporation

  • In April 2024, DuPont announced the launch of the addition of its roofing underlayment product line, the Tyvek Protec PSU peel-and-stick underlayment. The new product is designed to provide high-performance, high-temperature, and UV resistance, a slip-resistant walking surface, a split liner for easy installation, an ICC-ES code report, and prestigious FL/Miami-Dade certification.
  • In February 2024, Spectrum announced plans to expand its facility in Costa Rica, incorporating sterile DuPont Tyvek medical packaging capabilities and enhancing its medical tubing operations. The expansion of the Heredia facility from 36,000 square feet to 52,000 square feet aims to increase capacity and expedite service delivery.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.4 Impact of the Current Geo-political Scenarios on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Stringent Regulations Toward Infection Control Expected to Aid Demand for Sterile-based Products
    • 5.1.2 Recent Increase in Utilization Capacity
    • 5.1.3 Material Advancements in the Field of Plastics
  • 5.2 Market Challenges
    • 5.2.1 Dynamic Nature of Regulations Makes it Challenging for Manufacturers to Comply with Local Factors with Issues Related to Material Availability

6 MARKET SEGMENTATION

  • 6.1 By Material Type
    • 6.1.1 Plastic
      • 6.1.1.1 Polypropylene (PP)
      • 6.1.1.2 Polyester
      • 6.1.1.3 Polystyrene (PS)
      • 6.1.1.4 Polyvinyl Chloride (PVC), High-density Polyethylene (HDPE), etc
    • 6.1.2 Paper and Paperboard
    • 6.1.3 Glass
    • 6.1.4 Other Material Types
  • 6.2 By Product Type
    • 6.2.1 Thermoform Trays
    • 6.2.2 Sterile Bottles and Containers
    • 6.2.3 Pouches and Bags
    • 6.2.4 Blisters Packs
    • 6.2.5 Vials and Ampoules
    • 6.2.6 Pre-Filled Syringes
    • 6.2.7 Wraps
  • 6.3 By Application Type
    • 6.3.1 Pharmaceutical
    • 6.3.2 Surgical and Medical Appliances
    • 6.3.3 In Vitro Diagnostics (IVD)
    • 6.3.4 Other Applications
  • 6.4 By Sterilization Type
    • 6.4.1 Chemical Sterilization
    • 6.4.2 Radiation Sterilization
    • 6.4.3 Pressure/Temperature Sterilization
  • 6.5 By Geography***
    • 6.5.1 North America
    • 6.5.2 Europe
    • 6.5.3 Asia
    • 6.5.4 Australia and New Zealand
    • 6.5.5 Latin America
    • 6.5.6 Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles*
    • 7.1.1 Amcor Group GmbH
    • 7.1.2 Dupont De Nemours Inc.
    • 7.1.3 Steripack Group Limited
    • 7.1.4 Wipak Group
    • 7.1.5 Placon Corporation
    • 7.1.6 Riverside Medical Packaging Company Ltd
    • 7.1.7 Tekni-Plex Inc.
    • 7.1.8 BillerudKorsnas AB
    • 7.1.9 Sonoco Products Co
    • 7.1.10 DWK Life Sciences
    • 7.1.11 Technipaq Inc.
    • 7.1.12 3M Company
    • 7.1.13 Nelipak Healthcare Packaging
    • 7.1.14 Oliver Healthcare Packaging
    • 7.1.15 Beacon Converting Inc.
    • 7.1.16 Paxxus Inc.
    • 7.1.17 Spectrum Plastics Group
    • 7.1.18 Sterimed Holdings SaS
    • 7.1.19 Sigma Medical Supplies Corporation
    • 7.1.20 Charter Next Generation
    • 7.1.21 Berry Global Inc.
    • 7.1.22 Sealed Air Corporation

8 MARKET OUTLOOK